schrodinger inc - SDGR

SDGR

Close Chg Chg %
12.94 0.55 4.25%

Closed Market

13.49

+0.55 (4.25%)

Volume: 1.16M

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: schrodinger inc - SDGR

SDGR Key Data

Open

$13.16

Day Range

12.81 - 13.57

52 Week Range

12.81 - 28.45

Market Cap

$984.16M

Shares Outstanding

73.66M

Public Float

62.74M

Beta

1.57

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.40

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.30M

 

SDGR Performance

1 Week
 
-3.44%
 
1 Month
 
-26.64%
 
3 Months
 
-24.13%
 
1 Year
 
-47.45%
 
5 Years
 
-86.46%
 

SDGR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About schrodinger inc - SDGR

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

SDGR At a Glance

Schrödinger, Inc.
1540 Broadway
New York, New York 10036-4041
Phone 1-212-295-5800 Revenue 207.54M
Industry Packaged Software Net Income -187,123,000.00
Sector Technology Services Employees 891
Fiscal Year-end 12 / 2025
View SEC Filings

SDGR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 6.754
Price to Book Ratio 3.336
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -5.672
Enterprise Value to Sales 5.552
Total Debt to Enterprise Value 0.102

SDGR Efficiency

Revenue/Employee 232,928.171
Income Per Employee -210,014.59
Receivables Turnover 0.813
Total Asset Turnover 0.255

SDGR Liquidity

Current Ratio 3.312
Quick Ratio 3.312
Cash Ratio 1.916

SDGR Profitability

Gross Margin 63.642
Operating Margin -100.847
Pretax Margin -89.482
Net Margin -90.163
Return on Assets -23.014
Return on Equity -38.582
Return on Total Capital -34.699
Return on Invested Capital -31.66

SDGR Capital Structure

Total Debt to Total Equity 27.958
Total Debt to Total Capital 21.85
Total Debt to Total Assets 14.313
Long-Term Debt to Equity 23.983
Long-Term Debt to Total Capital 18.743
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Schrodinger Inc - SDGR

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
137.93M 180.96M 216.67M 207.54M
Sales Growth
+27.60% +31.19% +19.73% -4.21%
Cost of Goods Sold (COGS) incl D&A
74.30M 80.45M 76.56M 75.46M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.85M 4.34M 5.55M 6.16M
Depreciation
2.85M 3.83M 4.96M 6.16M
Amortization of Intangibles
- - 513.00K 587.00K
-
COGS Growth
+57.34% +8.27% -4.83% -1.44%
Gross Income
63.63M 100.51M 140.10M 132.08M
Gross Income Growth
+4.53% +57.96% +39.40% -5.73%
Gross Profit Margin
+46.13% +55.54% +64.66% +63.64%
2021 2022 2023 2024 5-year trend
SG&A Expense
175.07M 247.33M 317.55M 341.38M
Research & Development
90.09M 126.37M 181.77M 201.78M
Other SG&A
84.99M 120.95M 135.79M 139.59M
SGA Growth
+43.75% +41.27% +28.39% +7.50%
Other Operating Expense
- - - -
-
Unusual Expense
(11.36M) 18.08M (53.46M) (5.68M)
EBIT after Unusual Expense
(100.08M) (164.90M) (123.99M) (203.61M)
Non Operating Income/Expense
(724.00K) 15.78M 166.91M 17.90M
Non-Operating Interest Income
- - - 1.06M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(100.81M) (149.13M) 42.92M (185.71M)
Pretax Income Growth
-283.42% -47.93% +128.78% -532.70%
Pretax Margin
-73.09% -82.41% +19.81% -89.48%
Income Tax
411.00K 63.00K 2.20M 1.41M
Income Tax - Current - Domestic
67.00K (475.00K) 1.24M 150.00K
Income Tax - Current - Foreign
344.00K 538.00K 963.00K 1.51M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - (253.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(101.22M) (149.19M) 40.72M (187.12M)
Minority Interest Expense
- - (826.00K) (3.00K)
-
Net Income
(100.39M) (149.19M) 40.72M (187.12M)
Net Income Growth
-310.39% -48.60% +127.29% -559.54%
Net Margin Growth
-72.78% -82.44% +18.79% -90.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(100.39M) (149.19M) 40.72M (187.12M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(100.39M) (149.19M) 40.72M (187.12M)
EPS (Basic)
-1.4221 -2.0961 0.5673 -2.575
EPS (Basic) Growth
-248.90% -47.39% +127.06% -553.90%
Basic Shares Outstanding
70.59M 71.17M 71.78M 72.67M
EPS (Diluted)
-1.4221 -2.0961 0.543 -2.575
EPS (Diluted) Growth
-248.90% -47.39% +125.91% -574.22%
Diluted Shares Outstanding
70.59M 71.17M 74.99M 72.67M
EBITDA
(108.60M) (142.47M) (171.90M) (203.14M)
EBITDA Growth
-89.66% -31.20% -20.65% -18.17%
EBITDA Margin
-78.73% -78.73% -79.34% -97.88%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 25.00
Number of Ratings 10 Current Quarters Estimate -0.48
FY Report Date 03 / 2026 Current Year's Estimate -1.344
Last Quarter’s Earnings -0.22 Median PE on CY Estimate N/A
Year Ago Earnings -2.038 Next Fiscal Year Estimate -1.048
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 10 4
Mean Estimate -0.48 -0.33 -1.34 -1.05
High Estimates -0.39 0.86 0.03 -0.56
Low Estimate -0.62 -0.71 -2.33 -1.40
Coefficient of Variance -19.03 -161.79 -48.14 -34.38

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 6
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Schrodinger Inc - SDGR

Date Name Shares Transaction Value
Mar 11, 2025 Bridget A. van Kralingen Director 10,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 11, 2025 Bridget A. van Kralingen Director 17,050 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Yvonne Tran EVP, CLO & CPO 15,037 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $4.34 per share 65,260.58
Feb 20, 2025 Yvonne Tran EVP, CLO & CPO 11,135 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28 per share 311,780.00
Feb 20, 2025 Yvonne Tran EVP, CLO & CPO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 13, 2025 Robert Abel See Remarks 8,115 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $25.99 per share 210,908.85
Feb 13, 2025 Patrick Lorton EVP, CTO & COO, Software 41,076 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.43 per share 1,003,486.68
Feb 13, 2025 Jenny Herman SVP & Controller 18,215 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.43 per share 444,992.45

Schrodinger Inc in the News